CERTARA INC. - COMMON STOCK

Certara Completes Acquisition of Chemaxon

02 Oct 2024 16:15:00 By Nasdaq GlobeNewswire

Certara’s Simcyp Consortium Celebrates 25th Anniversary

24 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

18 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Certara to Participate in Upcoming Investor Conferences

21 Aug 2024 16:15:00 By Nasdaq GlobeNewswire

Certara Launches Phoenix™ Version 8.5 Drug Development Software

15 Aug 2024 16:15:00 By Nasdaq GlobeNewswire

Certara Reports Second Quarter 2024 Financial Results

06 Aug 2024 16:15:00 By Nasdaq GlobeNewswire

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

09 Jul 2024 16:45:00 By Nasdaq GlobeNewswire

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

02 Jul 2024 16:15:00 By Nasdaq GlobeNewswire

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

17 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Certara to Participate in the Jefferies Global Healthcare Conference

29 May 2024 16:15:00 By Nasdaq GlobeNewswire

Certara Appoints New Chief Human Resources Officer & General Counsel

21 May 2024 08:00:00 By Nasdaq GlobeNewswire

Certara Reports First Quarter 2024 Financial Results

07 May 2024 16:15:00 By Nasdaq GlobeNewswire

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

16 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Certara Reports Fourth Quarter 2023 Financial Results

29 Feb 2024 16:10:01 By Nasdaq GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

01 Feb 2024 16:30:00 By Nasdaq GlobeNewswire

Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

13 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  

21 Nov 2023 16:30:00 By Nasdaq GlobeNewswire

Certara Reports Third Quarter 2023 Financial Results

08 Nov 2023 16:10:01 By Nasdaq GlobeNewswire

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

11 Oct 2023 16:15:00 By Nasdaq GlobeNewswire

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

19 Sep 2023 08:15:00 By Nasdaq GlobeNewswire